Biomarker Testing in Cancer: Getting the Right Treatment to the Right Patient at the Right Time

Dive into the transformative power of biomarker testing in cancer care. Host Kim Thiboldeaux speaks with Lena Chaihorsky, SVP of Payer Innovation at Alva10, and Ryan Hutto, Head of Commercial Diagnostics at Pfizer Oncology, about how biomarker testing is advancing personalized medicine. Discover how this cutting-edge technology empowers patients, enhances diagnostic precision, and offers pathways to optimal treatment and cost savings. This episode also explores insurance coverage challenges, actionable results, and the critical role of employers in supporting personalized medicine.

NEBGH Voices is produced by: Deren Abrams, Adria Subbiondo, and Christian Waugh